Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastases.

Purpose: For step-and-shoot robotic stereotactic radiosurgery (SRS) the dose delivered over time, called local tumor-dose-rate (TDR), may strongly vary during treatment of multiple lesions. The authors sought to evaluate technical parameters influencing TDR and correlate TDR to clinical outcome.Mate...

Full description

Bibliographic Details
Published in:Strahlentherapie und Onkologie Vol. 197; no. 7; pp. 581 - 592
Main Authors: Wilhelm, Maria-Lisa, Chan, Mark K. H., Abel, Benedikt, Cremers, Florian, Siebert, Frank-Andre, Wurster, Stefan, Krug, David, Wolff, Robert, Dunst, Jürgen, Hildebrandt, Guido, Schweikard, Achim, Rades, Dirk, Ernst, Floris, Blanck, Oliver
Format: research Journal Article
Published: Springer Nature Jul2021
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151026152&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 151026152
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01797158
        NZE
      jtl: Strahlentherapie und Onkologie
      issn: 01797158
      maglogo: N
    pubinfo:
      dt: Jul2021
      vid: 197
      iid: 7
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        151026152
        144437253
        151026152
        NLM32588102
        151026152
        10.1007/s00066-020-01652-6
        NLM32588102
        151026152
      ppf: 581
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Tumor-dose-rate variations during robotic radiosurgery of oligo and multiple brain metastases.
      aug:
        au:
          Wilhelm, Maria-Lisa
          Chan, Mark K. H.
          Abel, Benedikt
          Cremers, Florian
          Siebert, Frank-Andre
          Wurster, Stefan
          Krug, David
          Wolff, Robert
          Dunst, Jürgen
          Hildebrandt, Guido
          Schweikard, Achim
          Rades, Dirk
          Ernst, Floris
          Blanck, Oliver
        affil: Department of Radiation Oncology, University Medicine Rostock, Rostock, Germany
      sug:
        subj:
          Radiosurgery Methods
          Brain Neoplasms Radiotherapy
          Radiation Dosage
          Retrospective Design
          Brain Neoplasms Surgery
          Treatment Outcomes
          Body Weights and Measures
          Human
          Robotic Surgical Procedures Methods
          Comparative Studies
          Multicenter Studies
          Evaluation Research
          Validation Studies
          Scales
      ab: Purpose: For step-and-shoot robotic stereotactic radiosurgery (SRS) the dose delivered over time, called local tumor-dose-rate (TDR), may strongly vary during treatment of multiple lesions. The authors sought to evaluate technical parameters influencing TDR and correlate TDR to clinical outcome.Material and Methods: A total of 23 patients with 162 oligo (1-3) and multiple (>3) brain metastases (OBM/MBM) treated in 33 SRS sessions were retrospectively analyzed. Median PTV were 0.11 cc (0.01-6.36 cc) and 0.50 cc (0.12-3.68 cc) for OBM and MBM, respectively. Prescription dose ranged from 16 to 20 Gy prescribed to the median 70% isodose line. The maximum dose-rate for planning target volume (PTV) percentage p in time span s during treatment (TDRs,p) was calculated for various p and s based on treatment log files and in-house software.Results: TDR60min,98% was 0.30 Gy/min (0.23-0.87 Gy/min) for OBM and 0.22 Gy/min (0.12-0.63 Gy/min) for MBM, respectively, and increased by 0.03 Gy/min per prescribed Gy. TDR60min,98% strongly correlated with treatment time (ρ = -0.717, p < 0.001), monitor units (MU) (ρ = -0.767, p < 0.001), number of beams (ρ = -0.755, p < 0.001) and beam directions (ρ = -0.685, p < 0.001) as well as lesions treated per collimator (ρ = -0.708, P < 0.001). Median overall survival (OS) was 20 months and 1‑ and 2‑year local control (LC) was 98.8% and 90.3%, respectively. LC did not correlate with any TDR, but tumor response (partial response [PR] or complete response [CR]) correlated with all TDR in univariate analysis (e.g., TDR60min,98%: hazard ration [HR] = 0.974, confidence interval [CI] = 0.952-0.996, p = 0.019). In multivariate analysis only concomitant targeted therapy or immunotherapy and breast cancer tumor histology remained a significant factor for tumor response. Local grade ≥2 radiation-induced tissue reactions were noted in 26.3% (OBM) and 5.2% (MBM), respectively, mainly influenced by tumor volume (p < 0.001).Conclusions: Large TDR variations are noted during MBM-SRS which mainly arise from prolonged treatment times. Clinically, low TDR corresponded with decreased local tumor responses, although the main influencing factor was concomitant medication.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N